NCT04858412View on ClinicalTrials.gov

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Alcoholic Liver DiseaseCOVID 19 Pneumonia
Interventions
DIETARY_SUPPLEMENT

β-hydroxy β-methyl butyrate (HMB) enriched amino acid

β-hydroxy β-methyl butyrate (HMB) is a non-nitrogenous leucine metabolite with anabolic properties.

DIETARY_SUPPLEMENT

Balanced amino acid

Balanced amino acid is the balanced mixture of the various essential amino acids.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER